The role of sodium-glucose cotransporter 2 inhibitors in diabetic nephropathy and non diabetic renal disease in diabetes mellitus type 2 patients
| dc.contributor.author | Ibernón, Meritxell | |
| dc.contributor.author | Navarro, Maru | |
| dc.contributor.author | Goma, Montserrat | |
| dc.contributor.author | Tango, Ariel | |
| dc.contributor.author | Rap, Oana | |
| dc.contributor.author | Cabrera, Cristina | |
| dc.contributor.author | Sánchez, Ana | |
| dc.contributor.author | Rodriguez, Neus | |
| dc.contributor.author | Ruiz, Pilar | |
| dc.date.accessioned | 2025-01-08T12:30:42Z | |
| dc.date.available | 2025-01-08T12:30:42Z | |
| dc.date.issued | 2024-05-01 | |
| dc.date.updated | 2024-12-13T10:02:40Z | |
| dc.description | Comunicació/presentació a: 61st ERA Congress, The European Renal Association, Estocolm, 23-26 maig 2024 | |
| dc.description.abstract | Diabetes Mellitus type 2 (DM2) leads to chronic kidney disease in a 30-40% of diabetic patients and it is the major cause of end stage renal disease (ESRD). The clinical course of diabetic kidney disease is very heterogeneous and there is a lack of agreement between clinical parameters and renal histology. Besides, lesions of non-diabetic kidney disease (NDRD) can coexist with lesions of diabetic nephropathy (DN) in two-thirds of kidney biopsies in patients with diabetes. | |
| dc.format.extent | 4 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.issn | 1460-2385 | |
| dc.identifier.uri | https://hdl.handle.net/2445/217320 | |
| dc.language.iso | eng | |
| dc.publisher | Oxford University Press (OUP) | |
| dc.relation.isformatof | Versió postprint del document publicat a: https://doi.org/10.1093/ndt/gfae069.1086 | |
| dc.relation.ispartof | Nephrology Dialysis Transplantation, 2024, vol. 39, sup. 1, p. i1768-i1771 | |
| dc.relation.uri | https://doi.org/10.1093/ndt/gfae069.1086 | |
| dc.rights | (c) Ibernón, Meritxell et al., 2024 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.source | Comunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | |
| dc.subject.classification | Nefropaties diabètiques | |
| dc.subject.classification | Diabetis no-insulinodependent | |
| dc.subject.classification | Malalties del ronyó | |
| dc.subject.other | Diabetic nephropathies | |
| dc.subject.other | Non-insulin-dependent diabetes | |
| dc.subject.other | Kidney diseases | |
| dc.title | The role of sodium-glucose cotransporter 2 inhibitors in diabetic nephropathy and non diabetic renal disease in diabetes mellitus type 2 patients | |
| dc.type | info:eu-repo/semantics/conferenceObject | |
| dc.type | info:eu-repo/semantics/acceptedVersion |
Fitxers
Paquet original
1 - 1 de 1
Carregant...
- Nom:
- gfae069-1086-1626.pdf
- Mida:
- 759.41 KB
- Format:
- Adobe Portable Document Format
Paquet de llicències
1 - 1 de 1
Carregant...
- Nom:
- license.txt
- Mida:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Descripció: